Navigation Links
Circle Medical Devices, Texcel Medical Merge to Form CIRTEC Medical Systems
Date:10/19/2009

SPRINGFIELD, Mass., Oct. 19 /PRNewswire/ -- Circle Medical Devices of Los Gatos, Calif., and Texcel Medical of Springfield, Mass., have merged to create CIRTEC Medical Systems, a leading provider of comprehensive medical product design and manufacturing solutions.

"The merger introduces CIRTEC Medical Systems to medical device manufacturers as a preeminent, globally-experienced, single-sourced solution from concept through high-volume finished goods manufacturing," said Barry Smith, Chief Executive Officer of CIRTEC Medical Systems (www.cirtecmed.com).

"CIRTEC Medical Systems combines the strength of Circle Medical's extensive design and development capability with Texcel Medical's exceptional development and manufacturing. This strategic union creates a strong, technically-driven, 130-person full-service medical device engineering and manufacturing industry resource that is deeply-experienced across all therapeutic categories. Moreover, our team has particular expertise in minimally invasive systems, active and passive implants, and medical electronics," Smith said.

Smith said the two firms have helped to create and accelerate the commercialization of more than 300 medical device technologies safely, rapidly, and cost-effectively. Clients range from start-up medical technology innovators to international medical device manufacturers.

CIRTEC Medical Systems operates from three locations across the U.S. -- Texcel's facility in Springfield, MA, and Circle Medical's locations in Minneapolis, MN, and Los Gatos, CA. Jerry Hansen is CIRTEC Medical Systems Executive Chairman and Founder; Larry Derose is Chairman and Founder; and Michael Forman is President and Chief Technology Officer (CTO).

The announcement follows news in August of Texcel Medical plans to expand its '/>"/>

SOURCE CIRTEC Medical Systems
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ ... into non-exclusive Development Agreements with Dexcom, Inc. to ... pumps with the Dexcom G5 and G6 continuous ... next generation pump platform with Dexcom,s future CGM ...
(Date:7/30/2015)... N.J. , July 30, 2015  Unichem Pharmaceuticals ... recalling one lot of Hydrochlorothiazide tablets 25 mg 1000-count ... initiated as a precautionary measure due to the identification ... the product. The risk associated with ... tablet is the increased probability of experiencing Clopidogrel,s side ...
(Date:7/30/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the second quarter ending June 30, 2015. ... organization.  We are excited to be near the completion ... conducted with topline results expected in the fourth quarter," ... Therapeutics, Inc. "Translarna is now commercially available in 12 ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... July 9 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ... improvement in rheumatoid arthritis (RA) patients in the recently completed ... up to 6 months. The groups treated with 100 ... qd (once a day) reported higher ACR 20, ACR 50, ...
... , THOUSAND OAKS, Calif., July 7 Amgen (Nasdaq: ... Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic ... patients with advanced breast cancer met its primary and ... Superiority was demonstrated for both delaying the time ...
Cached Medicine Technology:Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 2Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 3Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 5Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 6Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 7Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 2Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 3Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 4Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 5Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 6Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 7Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases 8
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons of ... unification of their Healthy Home mission with the HOPE Movement of EvolvHealth. In what ... of both companies have agreed to join their missions of purpose together to change ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a security ... have been behind the attack on Anthem Inc. which resulted in one of the ... hole attacks and spear phishing campaigns. , For Joe Caruso, founder and ...
(Date:8/1/2015)... ... August 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic ... very first small business donation to kick off the campaign for healing and Well-Being. ... legacy includes a complete line of raw, organic hair care products, as well as ...
(Date:8/1/2015)... ... ... Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) – began ... and heading north. Since that day, Phil has hiked over 1400 miles in nine states. ... family. He visited CCAR and left an inspirational message to his staff: “You can ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reputable source of authentic tickets for the ... Fans of every genre of music will have an act they are excited to ... the festival, the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, The Who, ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:March4thforWellBeing Foundation Kickoff 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3
... health committee is all set to tighten the screws ... days of public hearing starting on Jan 23, is ... will make submissions before the committee. ,Under ... the sponsorship of sports and other popular events by ...
... way that primary care is organized, delivered, financed, and ... were released today by the American College of Physicians ... the Nation's Health Care. ,The U.S. health ... medicine, the ACP reported in its January 2006 State ...
... viral culture system, which makes way for a better ... replication of virus// (isolated from patient) in non-transformed hepatocytes. ... in transformed cell lines. ,The study report ... transfected and serum-infected cultured human fetal hepatocytes,’ appears in ...
... been accomplished by people who have kept on trying when there ... ,A groundbreaking venture has been ... cancer-treatment, are mass-produced in the egg white of a certain breed ... is one of the leading causes of death in the world. ...
... known as microchimerism has been known for some years, that ... pregnancy, and that these may live on for many// years, ... still unclear as to whether the presence of such cells ... team has looked for maternal cells in children with type ...
... findings that point to yet another benefit of statins; improving ... prescribed for heart patients. They work by lowering the levels ... in arteries. ,The drugs have also been shown ... of heart disease from having a heart attack or stroke. ...
Cached Medicine News:Health News:Comprehensive Reforms to Move Toward Patient-Centered Care 2Health News:Comprehensive Reforms to Move Toward Patient-Centered Care 3Health News:A Breakthrough in the Study of Hepatitis C 2Health News:'Hen Factories' To Synthesize Cancer Drugs 2Health News:Stem Cells Passed From Mother to Child Live On and Make Insulin 2Health News:Statins Aid Survival in Lung Patients, Say Experts 2
Soft Non-Latex, Adjustable Flange Nasopharyngeal Airway. Pediatric sizes available. Non-Latex Mediprene material with soft elastic finish. Adjustable flange for a better fit and increased patient com...
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati...
Flexible vinyl with a rigid bite block. Guedel-style with three internal channels. Individually packaged, 48 per case. Latex Free....
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
Medicine Products: